Paper Details

  1. Home
  2. Paper Details

Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis.

Author: , AmazanEmmanuelle, BastienMarie, BeauchetAlain, BegonEdouard, BenetonNathalie, BilanPaul, BoulardClaire, CinottiElisa, CottencinAnne-Caroline, DelaunayJuliette, DescampsVincent, FougerousseAnne-Claire, GottliebJeremy, JacobzoneCaroline, KemulaMathilde, Kupfer-BessaguetIngrid, LivideanuBulai, MaccariFrançois, MahéEmmanuel, Mery-BossardLaure, ParierJosiane, PerrotJean-Luc, PhanCéline, PrignanoFrancesca, Quiles-TsimaratosNathalie, ReguiaiZiad, RomanelliMarco, Ruer-MulardMireille, SamimiMahtab, SteffMaud, Thomas-BeaulieuDomitille, Vermersch-LanglinAnnie

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

Anti-interleukin-17 therapy appears to be an effective and safe therapeutic option for psoriasis treatment in elderly patients.
Paper Details　
Original Abstract of the Article :
Anti-interleukin-17 agents have recently been developed for the treatment of psoriasis. This study evaluated the tolerance and effectiveness of anti-interleukin-17 agents for psoriasis in elderly patients in daily practice. A multicentre, retrospective study was performed, involving psoriatic patien...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309849/

データ提供：米国国立医学図書館（NLM）

Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis

Psoriasis, like a persistent desert sandstorm, can be a challenging and uncomfortable condition, particularly for elderly patients. This study, much like a group of researchers seeking a way to mitigate the effects of the storm, investigates the effectiveness and safety of anti-interleukin-17 therapies in elderly patients with psoriasis.

A New Oasis in the Desert of Psoriasis Treatment

This study, akin to a wellspring of hope in the vast desert of psoriasis treatment, explores the potential of anti-interleukin-17 therapies for elderly patients. The researchers find that these therapies are generally effective and safe, offering a promising new approach to managing this chronic condition. This study provides valuable insights into the treatment options available for elderly patients, helping them navigate the challenging landscape of psoriasis.

Protecting the Skin's Desert

This study, like a protective barrier against the harsh desert wind, emphasizes the importance of finding effective and safe treatment options for elderly patients with psoriasis. The researchers' findings demonstrate that anti-interleukin-17 therapies can be a valuable tool in managing this condition, offering relief from its uncomfortable symptoms and potentially improving quality of life. By understanding the nuances of psoriasis treatment in elderly patients, we can better protect their skin from the relentless desert storm of this chronic condition.

Dr.Camel's Conclusion

Psoriasis can be a challenging condition, particularly for elderly patients, much like a desert sandstorm that can be difficult to weather. This study offers a beacon of hope, highlighting the effectiveness and safety of anti-interleukin-17 therapies for this population. By understanding the benefits and risks of these treatments, healthcare providers can make informed decisions, ensuring that elderly patients receive the best possible care and experience relief from the discomfort of psoriasis.
Date :
  1. Date Completed 2021-06-23
  2. Date Revised 2022-10-21
Further Info :

Pubmed ID

33111960

DOI: Digital Object Identifier

PMC9309849

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.